statistiche ricercatore

Città	#
Moscow	111
Dallas	105
Singapore	76
Ashburn	71
San Jose	58
Southend	49
Hong Kong	47
Chandler	36
Verona	28
The Dalles	22
Ho Chi Minh City	19
Munich	19
New York	18
Beijing	16
Helsinki	14
Los Angeles	13
Hanoi	11
Dublin	9
Tokyo	8
Milan	7
Warsaw	7
Manchester	6
Buffalo	5
Chennai	5
Houston	5
London	5
Orem	5
São Paulo	5
Amsterdam	4
Boston	4
Brno	4
Dong Ket	4
Frankfurt am Main	4
Guarulhos	4
Jacksonville	4
Jinan	4
Montreal	4
Turku	4
Abuja	3
City of London	3
Council Bluffs	3
Denver	3
Johannesburg	3
Lancaster	3
Lawrence	3
Lomé	3
Monticelli Brusati	3
Princeton	3
San Giovanni Lupatoto	3
Seattle	3
Shenyang	3
Tashkent	3
Toronto	3
Wilmington	3
Americana	2
Atlanta	2
Boardman	2
Bragança	2
Can Tho	2
Capannori	2
Cotonou	2
Da Nang	2
Haiphong	2
Istanbul	2
Jiaxing	2
Lombard	2
Moreno	2
Mumbai	2
Nanjing	2
Ningbo	2
Nuremberg	2
Pordenone	2
Redmond	2
Redondo Beach	2
Rome	2
Sant'Ambrogio di Valpolicella	2
Santa Clara	2
Sydney	2
São José	2
Tel Aviv	2
Tianjin	2
Vinh	2
Amphawa	1
Annapolis	1
Aparecida de Goiânia	1
Aracaju	1
Araçuaí	1
Asti	1
Athens	1
Augusta	1
Aurangabad	1
Baghdad	1
Baku	1
Barcelona	1
Basseterre	1
Bathinda	1
Bengaluru	1
Bogotá	1
Bonfinópolis de Minas	1
Brisbane	1
Totale	942

Nome	#
Ablation Difficulty Score: Proposal of a new tool to predict success rate of percutaneous ablation for hepatocarcinoma	252
Role of Amylase-α2A Autoantibodies in the Diagnosis of Autoimmune Pancreatitis	207
Azathioprine Maintenance Therapy to Prevent Relapses in Autoimmune Pancreatitis	194
Circulating IgG4+ Plasmablast Count as a Diagnostic Tool in Autoimmune Pancreatitis	157
Chronic pancreatitis and nutritional support	131
Clinical features and long-term outcomes of patients with type 2 autoimmune pancreatitis	128
Branch Duct IPMN-Associated Acute Pancreatitis in a Large Single-Center Cohort Study	111
The effect of steroid therapy on pancreatic exocrine function in autoimmune pancreatitis	109
An update on improving long-term outcomes for patients with chronic pancreatitis post-surgery	108
Percutaneous ablation in perivascular-HCC: impact of liver parenchyma and characteristics of vascular structures on the outcomes	82
Olmesartan-related sprue-like enteropathy presenting as severe diarrhoea	20
Totale	1.499

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	6	0	0	0	0	0	0	0	0	0	0	2	4
2021/2022	25	1	5	0	4	0	3	0	1	0	1	1	9
2022/2023	86	3	9	5	21	4	17	0	13	6	0	8	0
2023/2024	103	2	4	5	9	6	17	3	5	0	4	35	13
2024/2025	245	16	13	18	34	9	10	27	7	15	10	28	58
2025/2026	926	50	71	75	168	252	60	56	54	87	53	0	0
Totale													1.499

CATALOGO DEI PRODOTTI DELLA RICERCA